Qing Chen1, Kai-Ting Li1, Si Tian1, Ting-He Yu2, Le-Hu Yu3, Hai-Dan Lin1, Ding-Qun Bai1. 1. 1 Department of Rehabilitation, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China. 2. 2 Department of Gynaecology and Obstetrics, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. 3. 3 Department of Rehabilitation, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Abstract
Photodynamic therapy is a clinically used, minimally invasive therapeutic procedure that involves the application of photosensitizers which can locate in target cells and so be irradiated at a corresponding wavelength. Laser light irradiation activation of photosensitizers generates free reactive oxygen species, which induces selective cytotoxic activity in target cells. Within recent years, aloe-emodin as a photosensitizer has been successfully applied in photodynamic therapy applications. Angiogenesis plays an important role in tumor growth and metastasis; thus, the development of a novel target treatment for angiogenesis is essential in order to improve treatment therapeutics for cancer treatment. An essential step in angiogenesis involves the formation of tube-like structures during matrix degradation, rearrangement, and apoptosis of endothelial cells. In the present study, we investigated the mechanisms of photocytotoxicity induced by aloe-emodin in human umbilical vein endothelial cells. Analysis of cell proliferation results noted a significant decrease in cultured cells which received various concentrations of aloe-emodin and photodynamic therapy-induced light doses. Additionally, mitochondrial mechanisms of apoptotic cell death were observed in aloe-emodin photodynamic therapy-treated cells, as tube formation assays noted angiogenesis suppression after treatment. The capacity of migration and invasion of human umbilical vein endothelial cells was measured using the transwell assay and demonstrated that aloe-emodin photodynamic therapy significantly inhibited the migration and invasion of human umbilical vein endothelial cells. The expression of p38, extracellular signal-regulated kinase, the c-Jun N-terminal kinases, and vascular endothelial growth factor suggested that the cellular metastasis was related to mitogen-activated protein kinase signal pathway. Furthermore, disorganization of F action cytoskeleton components was observed after aloe-emodin photodynamic therapy. Overall, the findings from this study suggest that aloe-emodin photodynamic therapy inhibited angiogenesis and cellular metastasis in human umbilical vein endothelial cells by activating the mitogen-activated protein kinase apoptotic signaling cell death pathway.
Photodynamic therapy is a clinically used, minimally invasive therapeutic procedure that involves the application of photosensitizers which can locate in target cells and so be irradiated at a corresponding wavelength. Laser light irradiation activation of photosensitizers generates free reactive oxygen species, which induces selective cytotoxic activity in target cells. Within recent years, aloe-emodin as a photosensitizer has been successfully applied in photodynamic therapy applications. Angiogenesis plays an important role in tumor growth and metastasis; thus, the development of a novel target treatment for angiogenesis is essential in order to improve treatment therapeutics for cancer treatment. An essential step in angiogenesis involves the formation of tube-like structures during matrix degradation, rearrangement, and apoptosis of endothelial cells. In the present study, we investigated the mechanisms of photocytotoxicity induced by aloe-emodin in human umbilical vein endothelial cells. Analysis of cell proliferation results noted a significant decrease in cultured cells which received various concentrations of aloe-emodin and photodynamic therapy-induced light doses. Additionally, mitochondrial mechanisms of apoptotic cell death were observed in aloe-emodin photodynamic therapy-treated cells, as tube formation assays noted angiogenesis suppression after treatment. The capacity of migration and invasion of human umbilical vein endothelial cells was measured using the transwell assay and demonstrated that aloe-emodin photodynamic therapy significantly inhibited the migration and invasion of human umbilical vein endothelial cells. The expression of p38, extracellular signal-regulated kinase, the c-Jun N-terminal kinases, and vascular endothelial growth factor suggested that the cellular metastasis was related to mitogen-activated protein kinase signal pathway. Furthermore, disorganization of F action cytoskeleton components was observed after aloe-emodin photodynamic therapy. Overall, the findings from this study suggest that aloe-emodin photodynamic therapy inhibited angiogenesis and cellular metastasis in human umbilical vein endothelial cells by activating the mitogen-activated protein kinase apoptotic signaling cell death pathway.
Entities:
Keywords:
MAPK signal pathway; aloe-emodin; angiogenesis; photodynamic therapy
Photodynamic therapy (PDT) is a new treatment that is minimally invasive and exerts
selective cytotoxicity for target cells. Study showed cancers of skin, bladder, lung,
esophagus, and cervix can be managed,[1] and the reactive oxygen species (ROS) will be produced when light irradiation works
on photosensitizers (PSs) and induces cytotoxicity.[2] There are 3 mechanisms of PDT: (1) PDT can direct cell killing; (2) PDT can devastate
the vasculature; and (3) PDT can initiate immune response. Photodynamic therapy can extend
the survival and improve the quality of life for patients with inoperable cancers.[3-5] Photodynamic therapy includes 3 essential elements: PS, light, and reactive oxygen.[6,7]Anthraquinone derivative, aloe-emodin (AE), is similar to hypericin in structure.[8,9] Previous studies had found that AE had anticancer capacity in high concentration
alone, such as 10 µm concentration.[10] Aloe-emodin displayed stronger anticancer effect than 5-aminolevulinic acid as a new PS.[11]Angiogenesis plays more and more important role in cancer metastasis.[12] Angiogenic factors attract endothelial cells and promote their proliferation.
Proliferating and secreting proteases can induce endothelial cells to form blood vessels and
enable them to migrate toward the tumor site by breaking open the blood vessels.
Proliferating endothelial cells then form new capillary tubes. Finally, the capillaries
provide a continuous blood flow for tumor cell metabolism and set up escaping avenues for
metastatic tumor cells.[13-16]The mitogen-activated protein kinase (MAPK) is a type of serine/threonine protein kinase.[17,18] Mitogen-activated protein kinase can be activated by growth factors, insulin,
environmental factors, and cytokines, which involved in a broad intracellular response by
the MAPK signaling pathway.[19,20] Studies found that MAPKs are involved in cell migration and invasion events partially.[21-23]In this study, AE-PDT induced cell apoptosis and inhibited the proliferation, angiogenesis,
migration, and invasion in human umbilical vein endothelial cells (HUVECs). At the same
time, we found that AE-PDT can induce apoptosis of HUVECs by activating MAPK signaling
pathway.
Materials and Method
Cells
Human umbilical vein endothelial cells (Shanghai Institute of Cell Biology, Shanghai,
China) were cultured in Dulbecco's modified Eagle's medium (DMEM) medium (Hyclone, Logan,
Utah) supplemented with 10% (vol/vol) fetal bovine serum (Bioind, Hyclone, Logan, Utah),
50 U/mL penicillin, and 50 μg/mL streptomycin (Hyclone, Logan, Utah) at 5% CO2
atmosphere and 37°C. Cells in the logarithmic growth phase were harvested for
experiments.
Photosensitizer
Aloe-emodin (Jiangxi Herb Fine Co Ltd, Jiang Xi, China; purity >98%) was dissolved in
dimethyl sulfoxide (Sigma-Aldrich, St Louis, Missouri) to prepare stock solution (100
mmol/L). The solutions were sterilized by filtration with a 0.22-μm membrane (Millipore,
Bedford, Massachusetts) and stored at −20°C. The stock solution was diluted with DMEM
medium (Hyclone) to the desired concentration.
Photodynamic Treatment
Four treatment groups were created: control, single AE, single light, and AE-PDT groups.
Cells and AEs were cocultured for 6 hours and then washed 2 times by phosphate-buffered
saline (PBS). Irradiations were performed using a blue LED device (430 nm) with a fluence
rate of 40 mW/cm2; by adjusting the exposure time, the total light energy was
4, 8, 12, or 16 J/cm2: total light dose (J/cm2) = fluence rate
(mW/cm2) × treatment time (seconds). Cells were maintained in complete medium
during and posttreatment before assays.
Cell Viability
The viability of HUVECs was detected with the WST-8 assay (WST-8 Cell Proliferation Assay
Kit, Dojindo, Japan). Absorbance was measured at 450 nm (Tecan Group Ltd, Mannedorf,
Switzerland), and the percentage of survival cell was calculated.
5-Ethynyl-2-Deoxyuridine Assay
Cells were incubated with 50 µM 5-ethynyl-2-deoxyuridine (EdU labeling/detection kit;
Ribobio, Guangzhou, China) for 12 hours and fixed with 4% paraformaldehyde (PA; pH 7.4)
for 30 minutes. Cells were incubated with glycine for 5 minutes. Then anti-EdU solution
was added into cells at room temperature and stored for 30 minutes after which cells were
washed in PBS containing 0.5% Triton X-100. Finally, 5 μg/mL Hoechst 33342 was added to
the cells and incubated for 30 minutes at room temperature to stain cellular nuclei and
observed under a fluorescence microscope (Nikon, Japan).
Tube Formation Assay
Subconfluent HUVECs were harvested, resuspended in medium, and treated with AE-PDT. This
suspension was seeded (70 000 cells/well) in Matrigel (Becton Dickinson, San Jose,
California; Matrigel:free medium = 1:1) in a 96-well plate and incubated for 24 hours at
37°C with 5% CO2. Tube formation was examined under an inverted microscope and
photographed at 40× magnification. Cumulative tube length was measured by using ImageJ software.[24] Results were shown as the mean and standard errors of triplicate experiments. [25]
Detection of ROS
Cells were cocultured with 2,7-dichlorodihydrofluorescein diactate (DCFH-DA) (Invitrogen,
Paisley, United Kingdom) in a concentration of 10 μM for 30 minutes and washed twice with
PBS. Then, the intracellular ROS were analyzed under fluorescence microscope (Nikon) and
Fluor spectrophotometer (Tecan Group Ltd; Excitation = 488 nm, Emission = 520 nm).
Assay for Apoptosis
Cells treated with AE-PDT were resuspended with 500 µL binding buffer and then incubated
with annexin fluorescein Isothiocyanate (V-FITC) and Propidium dioxide (PI) in a
Ca2+-enriched binding buffer for 5 minutes. FACS Canto flow cytometer (Becton
Dickinson) was used to determine whether the cellular death pathway was apoptotic or
necrotic.
Mitochondrial Membrane Potential
5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimidazolcarbocyanine iodide (JC-1) assay
was performed to detect the mitochondrial membrane potential. Cells were incubated with 5
µg/mL of JC-1 (Invitrogen) for 30 minutes. Then, the membrane potential was measured in
Spectra Fluor spectrophotometer (Tecan Group Ltd) and fluorescence microscopy (Nikon).
Western Blot Analysis
Cells were harvested and lysated with radio-Immunoprecipitation (RIPA) buffer (Sigma).
Lysates were separated by sodium dodecyl sulfatepolyacrylamide gel electrophoresis and
then transferred to nitrocellulose membranes (Millipore). Blots were incubated with
primary antibodies and secondary antibodies. Antibodies used in this study included Bcl-2,
caspase-9, matrix metalloproteinase (MMP) 2, and MMP9, from Santa Cruz Biotechnology
(Dallas, Texas); P-38, extracellular signal-regulated kinase (ERK), the c-Jun N-terminal
kinases (JNK), and vascular endothelial growth factor (VEGF) from Abcam (Cambridge,
Massachusetts); and caspase-3 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) from
Cell Signaling Technologies. The blots were developed by an enhanced chemiluminescence
(ECL) detection kit (Kaiji Bio Co, Nanjing, China) and visualized under LAS 3000
Luminoimage Analyzer. Three independent experiments were performed, and the representative
results were shown.
Cell Migration and Invasion
The migration or invasive ability of cells was detected by Transwell chamber system
(10-mm diameter of polycarbonate membrane with 8-mm pore size; Corning Costar, Cambridge,
Massachusetts) coated with or without Matrigel (Becton Dickinson). Briefly, 50 µL Matrigel
(Matrigel:free medium = 1:3) was added into transwell chambers and incubated at 37°C
overnight. After fixation in 4% PA (Nanjing Sunshine Biotechnology Ltd, Nanjing, China),
the cells invading through the membrane were stained with crystal violet (Nanjing Sunshine
Biotechnology Ltd). The migratory and invasive cells were counted by microscope.
Subcellular Localization of AE
During the last 30 minutes of AE incubation, cells were coloaded with Mito-Tracker green
at a final concentration of 500 nM to tag the mitochondria. An overlapped fluorescence
from organelle probe and AE was observed under confocal microscopy (TCS SP5; Leica).
Cytoskeleton
Cells were seeded into a 96-well plate at a density of 1 × 105/mL for 24 hours
and fixed with 4% PA (Nanjing Sunshine Biotechnology Ltd) for 10 minutes. Cells were
permeabilized in PBS containing 0.5% Triton X-100 for 10 minutes, stained with Alexa Fluor
488 phalloidin (Life technologies) for 1 hour, and mounted by microscope.
Transmission Electron Microscopy
Cells were fixed in 0.1 M cacodylate buffer containing 2.5% glutaraldehyde for 2 hours at
4°C, followed by a second fixation in 0.1 M cacodylate buffer containing 1% osmium
tetroxide for 1 hour at 4°C. After 3 washes in distilled H2O, the sample was
stained with 0.5% aqueous uranyl acetate for 2 hours at room temperature. Transmission
electron microscopy samples were observed using a JEOL1200EX instrument.
Statistical Analysis
Values were expressed as mean (standard deviation). The significance of differences
between treatment groups was performed with analysis of variance test or 2-tailed Student
t test. A value of P < .05 was considered
statistically significant.
Results
Aloe-Emodin PDT-Suppressed Cell Proliferation
Treatment groups consisted of control, single AE, single light, and AE-PDT groups. Figure 1 shows changes in cell
viability caused by different treatments. Aloe-emodin alone with a concentration of 20 μM
and light irradiation alone with a density not less than 16 J/cm2 significantly
decreased the cell survival (P < .05; Figure 1A). Thus, the concentration of AE was set at
15 μM, and the density of light irradiation was set at 12 J/cm2 in the
following experiments of AE-PDT, which led to a cell survival rate of 56%. The population
of EdU-positive cells was 35 ± 3, 34 ± 4, 32 ± 3, and 8 ± 2 in control, single AE, single
light, and AE-PDT groups, respectively. The EdU-positive cells significantly declined in
the AE-PDT group compared to the other 3 groups (P < .05; Figure 1B and C). No significant
differences were observed among the control, single AE, and single light groups
(P > .05).
Figure 1.
Aloe-emodin photodynamic therapy (AE-PDT) produced cytotoxicity and inhibited
proliferation of human umbilical vein endothelial cells (HUVECs). A, The viability of
cells was detected by the WST-8 assay. B, The expression of 5-ethynyl-2-deoxyuridine
(EdU) was detected by immunofluorescence, and morphology was observed by
phase-contrast visualization (EdU, ×400); EdU (red) and H-33342 (blue) staining of
DNA. (a) Control group, (b) single AE group, (c) single light group, and (d) AE-PDT
group. C, The number of EdU-positive cells. *The AE-PDT group versus control group,
P < .05. #The AE-PDT group versus single AE group,
P < .05. &The AE-PDT group versus single light group,
P < .05. Values were represented as mean (standard deviation
[SD]) of 3 independent determinations.
Aloe-emodin photodynamic therapy (AE-PDT) produced cytotoxicity and inhibited
proliferation of human umbilical vein endothelial cells (HUVECs). A, The viability of
cells was detected by the WST-8 assay. B, The expression of 5-ethynyl-2-deoxyuridine
(EdU) was detected by immunofluorescence, and morphology was observed by
phase-contrast visualization (EdU, ×400); EdU (red) and H-33342 (blue) staining of
DNA. (a) Control group, (b) single AE group, (c) single light group, and (d) AE-PDT
group. C, The number of EdU-positive cells. *The AE-PDT group versus control group,
P < .05. #The AE-PDT group versus single AE group,
P < .05. &The AE-PDT group versus single light group,
P < .05. Values were represented as mean (standard deviation
[SD]) of 3 independent determinations.
Aloe-Emodin PDT-Induced Apoptosis via the Mitochondria Pathway
Annexin V/PI staining demonstrated a significantly higher apoptotic percentage of death
cells in the AE-PDT group (P < .05), with a value of 28.8%. No
significant differences were observed among the other 3 groups (P >
.05; Figure 2A and B). JC-1
staining demonstrated that a significant decrease in mitochondrial membrane potential was
observed in the AE-PDT group (P < .05), whereas no significant
differences were observed among the other 3 groups (P > .05; Figure 2C and D). Furthermore, the
ratio of green to red fluorescence in the AE-PDT group increased to 2.3 times when
compared to the control group. It is suggested that AE-PDT induces apoptotic cell death in
HUVEC cells via the mitochondria pathway.
Figure 2.
A, Apoptosis detected by annexin V/PI double staining. B, The percentage of
apoptosis. C, Mitochondrial membrane potential detected by the JC-1 assay (×200). D,
The relative fluorescence intensity of mitochondrial membrane potential quantified by
Fluor spectrophotometer. Scale bar was 50 µm. *Aloe-emodin photodynamic therapy
(AE-PDT) group versus control group, P < .05. #The AE-PDT group
versus single AE group, P < .05. &The AE-PDT group versus
single light group, P < .05. Values were represented as mean
(standard deviation [SD]) of 3 independent experiments.
A, Apoptosis detected by annexin V/PI double staining. B, The percentage of
apoptosis. C, Mitochondrial membrane potential detected by the JC-1 assay (×200). D,
The relative fluorescence intensity of mitochondrial membrane potential quantified by
Fluor spectrophotometer. Scale bar was 50 µm. *Aloe-emodin photodynamic therapy
(AE-PDT) group versus control group, P < .05. #The AE-PDT group
versus single AE group, P < .05. &The AE-PDT group versus
single light group, P < .05. Values were represented as mean
(standard deviation [SD]) of 3 independent experiments.Mito-tracker was used to view the subcellular localization of AE in the HUVECs.
Overlapping regions (yellow) were regarded as the subcellular localization of AE. The
results showed that the fluorescence images of the mitochondria probe were partially
overlapping with the AE (Figure
3).
Figure 3.
Subcellular localization of aloe-emodin (AE) detected by confocal microscopy. Red
fluorescent corresponds to AE, while green fluorescent shows Mito-Tracker with which
shows the mitochondrion is stained. Yellow fluorescent indicates colocalization of red
and green fluorescence.
Subcellular localization of aloe-emodin (AE) detected by confocal microscopy. Red
fluorescent corresponds to AE, while green fluorescent shows Mito-Tracker with which
shows the mitochondrion is stained. Yellow fluorescent indicates colocalization of red
and green fluorescence.
The Expression of Caspase-9 and Caspase-3
The Western blot results showed that the expression of both caspase-9 and caspase-3 was
significantly amplified after AE-PDT (P < .05; Figure 4). These data also suggest that AE-PDT
induces apoptosis through the mitochondria pathway.
Figure 4.
A, Expression of caspase-9 and caspase-3. B-C, Quantitative analysis of protein
expression according to panels. The vertical axis represents the gray value of
caspase-9 and caspase-3. Each assay condition was done in triplicate. Data were
represented as means (standard deviation [SD]).
A, Expression of caspase-9 and caspase-3. B-C, Quantitative analysis of protein
expression according to panels. The vertical axis represents the gray value of
caspase-9 and caspase-3. Each assay condition was done in triplicate. Data were
represented as means (standard deviation [SD]).
Aloe-Emodin PDT Suppressed Cell Migration and Invasion
The average count of migratory cells in the AE-PDT group was 72 and significantly
decreased, while the one in the control, single AE, and single light groups were 288, 286,
and 282, respectively. The average number of invasive cells in the AE-PDT group was 19 and
significantly declined when compared to the control, single AE, or single light groups,
with values of 98, 93, and 92, respectively (P < .05; Figure 5A-C).
Figure 5.
Aloe-emodin photodynamic therapy (AE-PDT) inhibited the migration and invasion of
human umbilical vein endothelial cells (HUVECs). A, The AE-PDT suppressed cell
migration and invasion. The migration cells and invasion cells were stained by crystal
violet (up; crystal violet, ×100). B, The AE-PDT inhibited cell migration. C, The
AE-PDT inhibited cell invasion. (a) Control group, (b) single AE group, (c) single
light group, (d) AE-PDT group. *The AE-PDT group versus control group,
P < .05. #The AE-PDT group versus single AE group,
P < .05. &The AE-PDT group versus single light group,
P < .05. Each assay condition was done in triplicate. Data were
represented as means (standard deviation [SD]).
Aloe-emodin photodynamic therapy (AE-PDT) inhibited the migration and invasion of
human umbilical vein endothelial cells (HUVECs). A, The AE-PDT suppressed cell
migration and invasion. The migration cells and invasion cells were stained by crystal
violet (up; crystal violet, ×100). B, The AE-PDT inhibited cell migration. C, The
AE-PDT inhibited cell invasion. (a) Control group, (b) single AE group, (c) single
light group, (d) AE-PDT group. *The AE-PDT group versus control group,
P < .05. #The AE-PDT group versus single AE group,
P < .05. &The AE-PDT group versus single light group,
P < .05. Each assay condition was done in triplicate. Data were
represented as means (standard deviation [SD]).
Cytoskeleton Associated With Migration
Based on the data in cell migration, the effect of PDT on F-actin was explored using
TRITC-phalloidin. F-actin in the AE-PDT group was shorter than that in the control, single
AE, or single light groups, demonstrating a reduction in stress and the formation of
aggregates (Figure 6).
Figure 6.
Cytoskeleton associated with migration F-actin(green) was detected by
Phalloidin-TRITC. DNA(blue) was observed by Hochest-33342. Both were merged in HUVEC
cells.
Cytoskeleton associated with migration F-actin(green) was detected by
Phalloidin-TRITC. DNA(blue) was observed by Hochest-33342. Both were merged in HUVEC
cells.
Aloe-Emodin PDT Negatively Regulates Angiogenesis
Matrigel tubule formation assay was used as an in vitro model to study
the effect of AE-PDT on the capillary structure formation. As shown in Figure 7A, AE-PDT-treated cells
reduced branching points, tubule number, and length. Simultaneously, the number of HUVEC
capillary structures was significantly decreased by AE-PDT treatment (P
< .05; Figure 7B).
Taken together, these results indicate that AE-PDT may directly regulate angiogenesis
in vitro.
Figure 7.
A, The effect of Aloe-emodin photodynamic therapy (AE-PDT) on the capillary structure
formation was measured by using Matrigel tubule formation assay. (a) Control group,
(b) Single AE group, (c) Single light group, (d) AE-PDT group. B, The numbers of
formed capillary tubes in 4 groups were counted. *The AE-PDT group versus control
group, P < .05. #The AE-PDT group versus single AE group,
P < .05. &The AE-PDT group versus single light group,
P < .05. Values were represented as means (standard deviation
[SD]) of 3 independent determinations.
A, The effect of Aloe-emodin photodynamic therapy (AE-PDT) on the capillary structure
formation was measured by using Matrigel tubule formation assay. (a) Control group,
(b) Single AE group, (c) Single light group, (d) AE-PDT group. B, The numbers of
formed capillary tubes in 4 groups were counted. *The AE-PDT group versus control
group, P < .05. #The AE-PDT group versus single AE group,
P < .05. &The AE-PDT group versus single light group,
P < .05. Values were represented as means (standard deviation
[SD]) of 3 independent determinations.
Mechanism of AE-PDT in Cell Deactivation Level of ROS
Reactive oxygen species mediates damages to mitochondria, thereby inducing apoptosis.[17] DCFH-DA staining showed that more ROS was significantly produced in the AE-PDT
groups compared to the other 3 groups (P < .05; Figure 8B). The increase in ROS can be detected at 30
minutes and reached the peak at 1 hour after AE-PDT (Figure 8A and B). The data suggest that AE-PDT
generates ROS resulting in apoptosis.
Figure 8.
A, Reactive oxygen species (ROS) observed by DCFH-DA staining (DCFH-DA, ×200).
DCFH-DA is a nonfluorescent compound, but it can be hydrolyzed and then transferred to
DCF, which is highly fluorescent when cells generate ROS. B, Levels of ROS at 30
minutes, 1 hour, and 1.5 hours after aloe-emodin photodynamic therapy (AE-PDT),
detected by Fluor spectrophotometer. (a) Control group, (b) Single AE group, (c)
Single light group, (d-f): AE-PDT group 30 minutes, 1 hour, and 1.5 hours. *The AE-PDT
group versus control group, P < .05. #The AE-PDT group versus
single AE group, P < .05. &The AE-PDT group versus single
light group, P < .05. Values were represented as means (standard
deviation [SD]) of 3 independent determinations.
The Expression of p38, p-p38, ERK, p-ERK, JNK, p-JNK, and VEGF
Compared to the other 3 groups, the expression of p-p38 and p-ERK ascended, while the
expression of VEGF descended significantly in the AE-PDT group (P <
.05). However, no significant difference was found in the expression of p-JNK among the 4
groups (P > .05; Figure 9). These data suggest that MAPK signaling pathways are possibly involved
in the inhibition of metastasis of HUVECs induced by AE-PDT.
Figure 9.
The expression of p38, p-p38, ERK, p-ERK,JNK, p-JNK and VEGF. a: control, b:single AE
group, c:single light group, d: AE-PDT group.
A, Reactive oxygen species (ROS) observed by DCFH-DA staining (DCFH-DA, ×200).
DCFH-DA is a nonfluorescent compound, but it can be hydrolyzed and then transferred to
DCF, which is highly fluorescent when cells generate ROS. B, Levels of ROS at 30
minutes, 1 hour, and 1.5 hours after aloe-emodin photodynamic therapy (AE-PDT),
detected by Fluor spectrophotometer. (a) Control group, (b) Single AE group, (c)
Single light group, (d-f): AE-PDT group 30 minutes, 1 hour, and 1.5 hours. *The AE-PDT
group versus control group, P < .05. #The AE-PDT group versus
single AE group, P < .05. &The AE-PDT group versus single
light group, P < .05. Values were represented as means (standard
deviation [SD]) of 3 independent determinations.The expression of p38, p-p38, ERK, p-ERK,JNK, p-JNK and VEGF. a: control, b:single AE
group, c:single light group, d: AE-PDT group.
Discussion
Our data suggest that AE-PDT can inhibit cell proliferation, migration, invasion, and
angiogenesis and induce apoptosis. We also delineated the mechanisms. On the one hand, ROS
generated by AE-PDT triggers the HUVEC apoptosis through the mitochondria. On the other
hand, MAPK signaling pathways triggered by ROS may be involved in the inhibition of
angiogenesis, migration, and invasion in HUVEC induced by AE-PDT.Photodynamic therapy has advantages such as minimal toxicity to normal tissues and lack of
intrinsic or acquired resistance.[3] In general, the cardinal principium of PDT is that the PS is activated to generate
ROS and their derivatives. Then, cellular oxidative stress, tissue anoxia, vasculature
damage, and immune response are followed, which result in cell death.[26] An ideal PS, which plays a key role in PDT, should be ease of quality control, low
costs as well as good stability, and have a high absorbance coefficient at 400 to 800 nm
(blue to deep red). Aloe-emodin is such a novel compound, and the effects of AE-PDT require
investigation.Data in cytotoxic and EdU assays showed that AE-PDT suppressed cell proliferation. Annexin
V/PI staining demonstrated a higher percentage of apoptotic cells in group AE-PDT. The
apoptosis pathway was therefore explored. Given the short life and limited diffusion
distance of AE in biological systems (half-life <0.04 microseconds and acting radius of
action <0.02 μm), the primary site of photodamage coincides with the intracellular
localization of AE.[27] Thus, we detected the subcellular localization of AE. Our data suggested that AE was
localized mainly on the mitochondrion in HUVECs, which provoked us to seek the further
events of mitochondrion. Interestingly, JC-1 staining showed a decrease in mitochondrial
membrane potential in the AE-PDT group (Figure 2C-D). It is well known that, first the collapse of mitochondrial membrane
potential recruits procaspase-9 to form a multimeric protein complex, subsequently the
autoproteolytic activation of caspase-9 is followed, and then the activation of downstream
of caspase-3 is initiated to complete the apoptosis process.[28-30] The collapse of mitochondrial membrane potential as well as increase in caspase-9 and
caspase-3 found after AE-PDT in the present study demonstrates that AE-PDT induces apoptosis
via the mitochondria pathways.In the present study, the capacity of HUVEC migration and invasion was suppressed by AE-PDT
treatment. Moreover, F-actin, a key factor involved in cell proliferation and migration, was
also inhibited by the treatment of AE-PDT. It is now well established that migration and
invasion take part in the metastasis[31]; simultaneously, the process of angiogenesis is essential to the growth of both
primary and metastatic tumors.[32] Besides the inhibition of migration and invasion in HUVECs shown in the present
study, the Matrigel tubule formation assay and the expression of VEGF demonstrated that the
angiogenesis of HUVECs was also suppressed by AE-PDT. It has been found that many factors,
including positive and negative ones, take part in the angiogenesis and metastasis.[33,34] The MAPK pathway has been demonstrated to serve a critical role in the angiogenesis
and metastasis,[35,36] which provoked us to explore the change in MAPK pathway. The MAPK family consists of
the 3 kinases: the ERK, the stress-activated protein kinase/JNK, and p38. The activity and
the role of the MAPKs have, to some extent, been studied after PDT and are suspected to be
of importance in the cellular processes controlling death and survival after oxidative stress.[37,38] Study showed that the p38 activation serves as a death signal, the JNK activation
serves as a rescue signal, whereas the ERK activation has no influence on the treatment outcome.[39] Interestingly, our study showed that the expression of p-p38 and p-ERK ascended,
while the expression of p-JNK did not change after AE-PDT. Otherwise, the link between MAPK
pathway and cell angiogenesis as well as metastasis in colorectal cancer is well established.[23] It was indicated that activation of the Ras/Raf/MEK/ERK pathway was involved in the
regulation of VEGF (which is important in angiogenesis) in humancolorectal cancer.[21] Similarly, interactions between the cell surface urokinase plasminogen activator
receptor and integrins are crucial for tumor invasion and metastasis, and urokinase
plasminogen activator increases basal ERK activation.[22] The reduction in VEGF along with the augment of p-ERK and p-p38 was demonstrated in
this study, indicating that both VEGF and ERK, p38 signaling pathways are involved in the
suppression of angiogenesis and metastasis in HUVECs. Taken together, these results suggest
that AE-PDT inhibits cell proliferation, migration, invasion, and angiogenesis in which the
p38 and ERK MAPK signal pathways are involved.
Conclusion
In summary, AE-PDT induced cellular apoptotic cell death via the mitochondria pathways as
well as inhibited cell migration, invasion, and angiogenesis via p38 and ERK MAPK signal
pathways.
Authors: Patrizia Agostinis; Kristian Berg; Keith A Cengel; Thomas H Foster; Albert W Girotti; Sandra O Gollnick; Stephen M Hahn; Michael R Hamblin; Asta Juzeniene; David Kessel; Mladen Korbelik; Johan Moan; Pawel Mroz; Dominika Nowis; Jacques Piette; Brian C Wilson; Jakub Golab Journal: CA Cancer J Clin Date: 2011-05-26 Impact factor: 508.702
Authors: Harsh Pal Bais; Ramarao Vepachedu; Christopher B Lawrence; Frank R Stermitz; Jorge M Vivanco Journal: J Biol Chem Date: 2003-06-10 Impact factor: 5.157